HOME >> BIOLOGY >> NEWS
Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer

The number of lymph nodes that contain evidence of cancer is the best predictor of the effectiveness of adding chemotherapy and radiation to a treatment plan prior to surgery in individuals with oesophageal cancer, according to a study published last month in the Annals of Surgery. The authors say their finding is particularly important because the focus of recent pathological studies of response to neoadjuvant therapies has been on the primary tumour rather than nodal sites.

Multimodal neoadjuvant therapy---where suitable patients are given several cycles of drugs and radiation therapy before undergoing surgical procedures to remove their tumour---is increasingly being used by oncologists as a way to boost survival rates from oesophageal cancer which, even with the most radical surgery, remain low: only 50% of patients survive for 3 years. However, the evidence for which additional therapies work best is confusing and conflicting. What is more, although it is widely accepted that there is a group of patients in whom this approach works well, identifying who these patients are is no easy task.

To help find ways of pinpointing individuals who might respond best to neoadjuvant treatment, John Vincent Reynolds and colleagues followed the progress of 243 patients who were treated with chemotherapy and radiation before surgery over 5 years. They paid particular attention to the histomorphological responses of patients---changes in the structure and appearance of tissue samples when viewed under a microscope---in addition to assessing prognosis using the traditional TNM method of staging, which takes into account tumour size, involvement of lymph nodes (nodal status), and presence or absence of metastases.

The study group consisted of all patients undergoing neoadjuvant treatment for oesophageal cancer at St James Hospital in Dublin,Ireland. Patients with oesophageal cancer were deemed suitable for multimodal therapy if they fulfilled
'"/>

Contact: Corinne Hall
mediaservice@esoncology.org
39-028-546-4522
European School of Oncology
13-Jul-2007


Page: 1 2 3

Related biology news :

1. MU researchers to study the status of black bears in Missouri
2. Green sturgeon receives threatened status
3. High-status monkeys ignore the interests of riff-raff
4. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible status
5. Sudden change in social status triggers genetic response in male fish, study finds
6. Manatee eyes could be window to health status
7. Location, location, location: Effect of nuclear organization on transcriptional status
8. Biologists findings on fertility and status in monkeys generate scientific, media interest
9. MIDI, Inc receives Official Methods(SM) status for the confirmatory ID of the anthrax pathogen
10. Study in Royal Society journal on how relationship status influences sex ratios
11. DNA highly promising predictor for successful treatment of alcoholics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/13/2020)... ... March 13, 2020 , ... ... lifespan of stored cord blood performed by Dr. Hal Boxmeyer and colleagues, which ... time for cryogenically preserved cells under proper conditions. Cryo-Cell International marks the first ...
(Date:3/10/2020)... ... 2020 , ... Cytonus Therapeutics Inc. today announced that Manisha ... President of Strategic Initiatives, Portfolio Innovation and Investor Relations at Allergan, plc. ... extremely pleased to welcome Manisha Narasimhan as an independent director," commented Christopher Thorne, ...
(Date:3/5/2020)... ... March 05, 2020 , ... Diagenode, ... and MGI Tech (MGI), a subsidiary of global genomics leader BGI Group, today ... the United States, Europe and Asia Pacific. , Under the terms of ...
Breaking Biology News(10 mins):
(Date:2/26/2020)... ... 2020 , ... Continuing its leading research on human milk ... safety assessment on the biotechnologically produced 3-Fucolsyllactose (3-FL) HMO. , 3-FL is ... are indigestible and therefore function as a prebiotic by promoting early microbial colonization ...
(Date:2/21/2020)... ... February 20, 2020 , ... The dietary ... reassuring consumers that what’s listed on an ingredient panel is actually in their ... this solution with the adoption of CertainT, which is designed to protect the ...
(Date:2/19/2020)... ... 18, 2020 , ... Shoreline Biome, a microbiome ... level, recently unveiled a novel DNA isolation product. , Shoreline Rapid Prep is ... molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB from Gram-negative ...
(Date:2/13/2020)... ... February 12, 2020 , ... Arriello , ... is adopting Veeva Vault Safety™ as part of the company’s continued ... of data, processing of safety information such as SUSARs and ICSRS, aggregate report ...
Breaking Biology Technology:
Cached News: